These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8105118)

  • 21. DNA-based prenatal diagnosis in a Chinese family with xeroderma pigmentosum group A.
    Yang Y; Ding B; Wang K; Bu D; Tu P; Zhu X
    Br J Dermatol; 2004 Jun; 150(6):1190-3. PubMed ID: 15214909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical symptoms and DNA repair characteristics of xeroderma pigmentosum patients from Germany.
    Thielmann HW; Popanda O; Edler L; Jung EG
    Cancer Res; 1991 Jul; 51(13):3456-70. PubMed ID: 2054785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defects in the DNA repair and transcription gene ERCC2 in the cancer-prone disorder xeroderma pigmentosum group D.
    Takayama K; Salazar EP; Lehmann A; Stefanini M; Thompson LH; Weber CA
    Cancer Res; 1995 Dec; 55(23):5656-63. PubMed ID: 7585650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between DNA repair-deficiency and high level of p53 mutations in melanoma of Xeroderma pigmentosum.
    Spatz A; Giglia-Mari G; Benhamou S; Sarasin A
    Cancer Res; 2001 Mar; 61(6):2480-6. PubMed ID: 11289118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations in the XPC gene in families with xeroderma pigmentosum and consequences at the cell, protein, and transcript levels.
    Chavanne F; Broughton BC; Pietra D; Nardo T; Browitt A; Lehmann AR; Stefanini M
    Cancer Res; 2000 Apr; 60(7):1974-82. PubMed ID: 10766188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C.
    Giglia G; Dumaz N; Drougard C; Avril MF; Daya-Grosjean L; Sarasin A
    Cancer Res; 1998 Oct; 58(19):4402-9. PubMed ID: 9766670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severe phenotypes in two Tunisian families with novel XPA mutations: evidence for a correlation between mutation location and disease severity.
    Messaoud O; Rekaya MB; Ouragini H; Benfadhel S; Azaiez H; Kefi R; Gouider-Khouja N; Mokhtar I; Amouri A; Boubaker MS; Zghal M; Abdelhak S
    Arch Dermatol Res; 2012 Mar; 304(2):171-6. PubMed ID: 22081045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced XPC DNA repair gene mRNA levels in clinically normal parents of xeroderma pigmentosum patients.
    Khan SG; Oh KS; Shahlavi T; Ueda T; Busch DB; Inui H; Emmert S; Imoto K; Muniz-Medina V; Baker CC; DiGiovanna JJ; Schmidt D; Khadavi A; Metin A; Gozukara E; Slor H; Sarasin A; Kraemer KH
    Carcinogenesis; 2006 Jan; 27(1):84-94. PubMed ID: 16081512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of splicing mutations of the last nucleotides of exons, a nonsense mutation, and a missense mutation of the XPAC gene as causes of group A xeroderma pigmentosum.
    Satokata I; Tanaka K; Yuba S; Okada Y
    Mutat Res; 1992 Mar; 273(2):203-12. PubMed ID: 1372103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel XPC pathogenic variant detected in archival material from a patient diagnosed with Xeroderma Pigmentosum: a case report and review of the genetic variants reported in XPC.
    Rivera-Begeman A; McDaniel LD; Schultz RA; Friedberg EC
    DNA Repair (Amst); 2007 Jan; 6(1):100-14. PubMed ID: 17079196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PCR-RFLP analysis as an aid to genetic counseling of families of Japanese patients with group A xeroderma pigmentosum.
    Maeda T; Sato K; Minami H; Taguchi H; Yoshikawa K
    J Invest Dermatol; 1997 Sep; 109(3):306-9. PubMed ID: 9284095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of the clinical manifestations and gene mutations of Japanese xeroderma pigmentosum group A patients.
    Kondoh M; Ueda M; Ichihashi M
    Br J Dermatol; 1995 Oct; 133(4):579-85. PubMed ID: 7577588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Xeroderma pigmentosum variant with multisystem involvement.
    Hessel A; Siegle RJ; Mitchell DL; Cleaver JE
    Arch Dermatol; 1992 Sep; 128(9):1233-7. PubMed ID: 1519938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular basis of group A xeroderma pigmentosum: a missense mutation and two deletions located in a zinc finger consensus sequence of the XPAC gene.
    Satokata I; Tanaka K; Okada Y
    Hum Genet; 1992 Mar; 88(6):603-7. PubMed ID: 1339397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Homozygous R788W point mutation in the XPF gene of a patient with xeroderma pigmentosum and late-onset neurologic disease.
    Sijbers AM; van Voorst Vader PC; Snoek JW; Raams A; Jaspers NG; Kleijer WJ
    J Invest Dermatol; 1998 May; 110(5):832-6. PubMed ID: 9579555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of molecular defects in xeroderma pigmentosum group C.
    Li L; Bales ES; Peterson CA; Legerski RJ
    Nat Genet; 1993 Dec; 5(4):413-7. PubMed ID: 8298653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutations in the XPD gene in xeroderma pigmentosum group D cell strains: confirmation of genotype-phenotype correlation.
    Kobayashi T; Uchiyama M; Fukuro S; Tanaka K
    Am J Med Genet; 2002 Jul; 110(3):248-52. PubMed ID: 12116233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Xeroderma pigmentosum].
    Takeuchi S
    Nihon Rinsho; 2000 Jul; 58(7):1496-500. PubMed ID: 10921330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prenatal diagnosis of xeroderma pigmentosum group A in Japan.
    Moriwaki S; Yamashita Y; Nakamura S; Fujita D; Kohyama J; Takigawa M; Ohmichi M
    J Dermatol; 2012 Jun; 39(6):516-9. PubMed ID: 22168765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Xeroderma pigmentosum].
    Ueda M; Ichihashi M
    Nihon Rinsho; 1995 Nov; 53(11):2815-20. PubMed ID: 8538050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.